Eligible participants must meet the following criteria:
-Be 50 to 90 years old.
-Have been diagnosed with mild to moderate Alzheimer’s Disease.
-Have a caregiver or family member who will attend study visits, report on daily activities and oversee taking medication.
*Other criteria may apply.
Participants who qualify may receive the investigational drug at no cost, and reimbursement for study related travel expenses may be provided.
If you are interested in participating in this study, please complete the following preliminary qualification form.
We will follow-up with you after we have received your submission.